title: [New developments in the diagnosis of benign prostatic hyperplasia].
abstract: The first phase in the diagnosis of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is to exclude another disease. This initial evaluation consist of anamnesis, including the quantification of symptoms according to the International Prostatic Symptom Score, physical examination--with digital rectal examination playing a central role, urinalysis, and renal function assessment; the prostate-specific antigen may suggest prostate cancer or may predict the volume of the prostate and the natural evolution of the disease. If, after the initial evaluation, the diagnosis is still uncertain, further investigations are necessary: imagistic exploration of the urinary tract, urodynamic tests or urethro-cystoscopy. The authors review current knowledge.
authors.affiliation: Spitalul Clinic Militar de Urgenţă "Dr. Iacob Czihac", Clinica Chirurgie.
authors.forename: M
authors.initials: M
authors.lastname: Vaida
authors.forename: B
authors.initials: B
authors.lastname: Novac
authors.forename: V
authors.initials: V
authors.lastname: Gheorghiu
authors.forename: C
authors.initials: C
authors.lastname: Novac
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D003558:Cystoscopy; D003937:Diagnosis, Differential; D051517:Digital Rectal Examination / Q000379:methods; D006801:Humans; D008297:Male; D008487:Medical History Taking; D010808:Physical Examination; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis*; D011788:Quality of Life; D012720:Severity of Illness Index; D016482:Urinalysis; D014555:Urination Disorders / Q000209:etiology; D014563:Urodynamics
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen